GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 287 filers reported holding GW PHARMACEUTICALS PLC in Q1 2020. The put-call ratio across all filers is 1.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,901,000 | +95.4% | 33,801 | +64.9% | 0.80% | +102.3% |
| Q3 2020 | $1,996,000 | -82.9% | 20,501 | -78.4% | 0.40% | -88.4% |
| Q2 2020 | $11,656,000 | -20.8% | 94,984 | -43.5% | 3.40% | -31.0% |
| Q1 2020 | $14,716,000 | -24.2% | 168,044 | -9.5% | 4.93% | +6.6% |
| Q4 2019 | $19,423,000 | -6.0% | 185,757 | +3.4% | 4.63% | -30.5% |
| Q3 2019 | $20,673,000 | -3.4% | 179,714 | +44.7% | 6.66% | +29.0% |
| Q2 2019 | $21,405,000 | +12.4% | 124,164 | +9.9% | 5.16% | +0.4% |
| Q1 2019 | $19,046,000 | +132.3% | 112,986 | +34.2% | 5.14% | +72.2% |
| Q4 2018 | $8,199,000 | +447.0% | 84,186 | +683.9% | 2.99% | +260.2% |
| Q2 2018 | $1,499,000 | -40.2% | 10,740 | -43.5% | 0.83% | -41.4% |
| Q4 2017 | $2,508,000 | – | 19,000 | – | 1.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
| Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
| Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
| Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
| CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
| FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
| Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
| PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |